Global Precision Medicine Market Insights, Research, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 126

Report ID: 9437

The global Precision Medicine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Precision Medicine market based on company, product type, end user and key regions.

This report studies the global market size of Precision Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Precision Medicine in these regions.
This research report categorizes the global Precision Medicine market by top players/brands, region, type and end user. This report also studies the global Precision Medicine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
IBM
GE Healthcare
Illumina
Roche
Laboratory Corporation of America Holdings
Thermo Fisher Scientific
Novartis
Abbott Laboratories
Almac Group
Intel Corporation
Biomrieux Sa
Cepheid
Qiagen
Randox Laboratories
Healthcore

Market size by Product
Diagnostics
Therapies
Market size by End User
Oncology
Neurosciences
Immunology
Respiratory
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Precision Medicine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Precision Medicine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Precision Medicine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Precision Medicine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Precision Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Precision Medicine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Precision Medicine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Precision Medicine Market Size Growth Rate by Product
1.4.2 Diagnostics
1.4.3 Therapies
1.5 Market by End User
1.5.1 Global Precision Medicine Market Size Growth Rate by End User
1.5.2 Oncology
1.5.3 Neurosciences
1.5.4 Immunology
1.5.5 Respiratory
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Precision Medicine Market Size
2.1.1 Global Precision Medicine Revenue 2014-2025
2.1.2 Global Precision Medicine Sales 2014-2025
2.2 Precision Medicine Growth Rate by Regions
2.2.1 Global Precision Medicine Sales by Regions
2.2.2 Global Precision Medicine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Precision Medicine Sales by Manufacturers
3.1.1 Precision Medicine Sales by Manufacturers
3.1.2 Precision Medicine Sales Market Share by Manufacturers
3.1.3 Global Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.2 Precision Medicine Revenue by Manufacturers
3.2.1 Precision Medicine Revenue by Manufacturers (2014-2019)
3.2.2 Precision Medicine Revenue Share by Manufacturers (2014-2019)
3.3 Precision Medicine Price by Manufacturers
3.4 Precision Medicine Manufacturing Base Distribution, Product Types
3.4.1 Precision Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Precision Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Precision Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Precision Medicine Sales by Product
4.2 Global Precision Medicine Revenue by Product
4.3 Precision Medicine Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Precision Medicine Breakdown Data by End User

6 North America
6.1 North America Precision Medicine by Countries
6.1.1 North America Precision Medicine Sales by Countries
6.1.2 North America Precision Medicine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Precision Medicine by Product
6.3 North America Precision Medicine by End User

7 Europe
7.1 Europe Precision Medicine by Countries
7.1.1 Europe Precision Medicine Sales by Countries
7.1.2 Europe Precision Medicine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Precision Medicine by Product
7.3 Europe Precision Medicine by End User

8 Asia Pacific
8.1 Asia Pacific Precision Medicine by Countries
8.1.1 Asia Pacific Precision Medicine Sales by Countries
8.1.2 Asia Pacific Precision Medicine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Precision Medicine by Product
8.3 Asia Pacific Precision Medicine by End User

9 Central & South America
9.1 Central & South America Precision Medicine by Countries
9.1.1 Central & South America Precision Medicine Sales by Countries
9.1.2 Central & South America Precision Medicine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Precision Medicine by Product
9.3 Central & South America Precision Medicine by End User

10 Middle East and Africa
10.1 Middle East and Africa Precision Medicine by Countries
10.1.1 Middle East and Africa Precision Medicine Sales by Countries
10.1.2 Middle East and Africa Precision Medicine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Precision Medicine by Product
10.3 Middle East and Africa Precision Medicine by End User

11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Company Business Overview
11.1.3 Johnson & Johnson Precision Medicine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Johnson & Johnson Precision Medicine Products Offered
11.1.5 Johnson & Johnson Recent Development
11.2 IBM
11.2.1 IBM Company Details
11.2.2 Company Business Overview
11.2.3 IBM Precision Medicine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 IBM Precision Medicine Products Offered
11.2.5 IBM Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 Company Business Overview
11.3.3 GE Healthcare Precision Medicine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GE Healthcare Precision Medicine Products Offered
11.3.5 GE Healthcare Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Company Business Overview
11.4.3 Illumina Precision Medicine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Illumina Precision Medicine Products Offered
11.4.5 Illumina Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Company Business Overview
11.5.3 Roche Precision Medicine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Roche Precision Medicine Products Offered
11.5.5 Roche Recent Development
11.6 Laboratory Corporation of America Holdings
11.6.1 Laboratory Corporation of America Holdings Company Details
11.6.2 Company Business Overview
11.6.3 Laboratory Corporation of America Holdings Precision Medicine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Laboratory Corporation of America Holdings Precision Medicine Products Offered
11.6.5 Laboratory Corporation of America Holdings Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Company Business Overview
11.7.3 Thermo Fisher Scientific Precision Medicine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Thermo Fisher Scientific Precision Medicine Products Offered
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Precision Medicine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Novartis Precision Medicine Products Offered
11.8.5 Novartis Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Company Business Overview
11.9.3 Abbott Laboratories Precision Medicine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Abbott Laboratories Precision Medicine Products Offered
11.9.5 Abbott Laboratories Recent Development
11.10 Almac Group
11.10.1 Almac Group Company Details
11.10.2 Company Business Overview
11.10.3 Almac Group Precision Medicine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Almac Group Precision Medicine Products Offered
11.10.5 Almac Group Recent Development
11.11 Intel Corporation
11.12 Biomrieux Sa
11.13 Cepheid
11.14 Qiagen
11.15 Randox Laboratories
11.16 Healthcore

12 Future Forecast
12.1 Precision Medicine Market Forecast by Regions
12.1.1 Global Precision Medicine Sales Forecast by Regions 2019-2025
12.1.2 Global Precision Medicine Revenue Forecast by Regions 2019-2025
12.2 Precision Medicine Market Forecast by Product
12.2.1 Global Precision Medicine Sales Forecast by Product 2019-2025
12.2.2 Global Precision Medicine Revenue Forecast by Product 2019-2025
12.3 Precision Medicine Market Forecast by End User
12.4 North America Precision Medicine Forecast
12.5 Europe Precision Medicine Forecast
12.6 Asia Pacific Precision Medicine Forecast
12.7 Central & South America Precision Medicine Forecast
12.8 Middle East and Africa Precision Medicine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Precision Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer